These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8877991)

  • 21. Doppler study of mesenteric, hepatic, and portal circulation in alcoholic cirrhosis: relationship between quantitative Doppler measurements and the severity of portal hypertension and hepatic failure.
    Taourel P; Blanc P; Dauzat M; Chabre M; Pradel J; Gallix B; Larrey D; Bruel JM
    Hepatology; 1998 Oct; 28(4):932-6. PubMed ID: 9755228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of long-term octreotide treatment on the response of portal-systemic collaterals to vasopressin in portal hypertensive rats.
    Wang SS; Chan CC; Lee FY; Chang FY; Lin HC; Chen CT; Huang HC; Tai CC; Lai IN; Lee SD
    Eur J Clin Invest; 2002 May; 32(5):316-21. PubMed ID: 12027870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined hepatic vein, umbilicoportal vein, and superior mesenteric artery catheterization in portal hypertension: estimation of the portal fraction of total hepatic blood flow in cirrhotic patients.
    Huet PM; Lavoie P; Légaré A; Viallet A
    Yale J Biol Med; 1975 Mar; 48(1):55-66. PubMed ID: 1130101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis.
    Bolognesi M; Sacerdoti D; Merkel C; Caregaro L; Bellon S; Gatta A
    Bildgebung; 1995 Jun; 62(2):138-43. PubMed ID: 7663138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Portal hemodynamics during nitroglycerin administration in cirrhotic patients.
    Garcia-Tsao G; Groszmann RJ
    Hepatology; 1987; 7(5):805-9. PubMed ID: 3115881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic effects of 8-day DL-028 and octreotide administration in rats with portal hypertension.
    Huang YT; Wu HL; Chern JW; Lin HC; Hong CY
    Scand J Gastroenterol; 1998 Dec; 33(12):1303-9. PubMed ID: 9930395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lanreotide effect on splanchnic blood flow in healthy subjects: effect of the rate of infusion.
    Sieber CC; Beglinger C; Bart S; Tschoepl M; Currie G; Larsen F; Drewe J
    Clin Pharmacol Ther; 2004 Jan; 75(1):70-9. PubMed ID: 14749693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of long-term administration of octreotide in portal vein-stenosed rats.
    Lin HC; Yang MC; Hou MC; Li SM; Huang YT; Yu PC; Tsai YT; Lee SD
    Hepatology; 1996 Mar; 23(3):537-43. PubMed ID: 8617434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic effects of terlipressin and octreotide administration alone or in combination in portal hypertensive rats.
    Oberti F; Veal N; Kaassis M; Pilette C; Rifflet H; Trouvé R; Calès P
    J Hepatol; 1998 Jul; 29(1):103-11. PubMed ID: 9696498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
    Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of vasopressin on esophageal varices blood flow in patients with cirrhosis: comparisons with the effects on portal vein and superior mesenteric artery blood flow.
    Iwao T; Toyonaga A; Oho K; Shigemori H; Sakai T; Tayama C; Masumoto H; Sato M; Tanikawa K
    J Hepatol; 1996 Oct; 25(4):491-7. PubMed ID: 8912148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short term effects of valsartan on portal blood flow in cirrhotic patients.
    Yalniz M; Demir A; Arslan A; Cihangiroğlu M
    Turk J Gastroenterol; 2003 Mar; 14(1):18-25. PubMed ID: 14593533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Portal and systemic hemodynamic responses to a very low dose of nitroglycerin in cirrhotic patients with portal hypertension.
    Kurokawa H; Sekiyama T; Katsuta Y; Aramaki T
    Nihon Ika Daigaku Zasshi; 1995 Feb; 62(1):2-12. PubMed ID: 7721974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis.
    Lin HC; Tsai YT; Lee FY; Lee SD; Hsia HC; Lin WJ; Lo KJ
    Gastroenterology; 1992 Jul; 103(1):229-34. PubMed ID: 1612330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of octreotide in patients with cirrhosis and portal hypertension; relationship between the plasma levels of the analogue and the magnitude and duration of the reduction in corrected wedged hepatic venous pressure.
    Jenkins SA; Nott DM; Baxter JN
    HPB Surg; 1998; 11(1):13-21. PubMed ID: 9830576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of liver hemodynamics according to doppler ultrasonography in alcoholic patients subtyped by Cloninger classification and non-alcoholic healthy subjects.
    Sumru Cosar Z; Cosar B; Oktar S; Arikan Z; Özdemir H; Yücel C
    Acta Neuropsychiatr; 2006 Feb; 18(1):7-14. PubMed ID: 26991976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of a long-acting formulation of octreotide on renal function and renal sodium handling in cirrhotic patients with portal hypertension: a randomized, double-blind, controlled trial.
    Ottesen LH; Aagaard NK; Kiszka-Kanowitz M; Rehling M; Henriksen JH; Pedersen EB; Flyvbjerg A; Bendtsen F
    Hepatology; 2001 Sep; 34(3):471-7. PubMed ID: 11526531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment.
    Merkel C; Sacerdoti D; Bolognesi M; Bombonato G; Gatta A
    J Hepatol; 1998 Apr; 28(4):622-30. PubMed ID: 9566831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic effects of eight-day octreotide and propranolol administration in portal hypertensive rats.
    Huang YT; Cheng YR; Lin HC; Hou MC; Lee SD; Hong CY
    Dig Dis Sci; 1998 Feb; 43(2):358-64. PubMed ID: 9512131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term effects of propranolol on portal venous pressure.
    Garcia-Tsao G; Grace ND; Groszmann RJ; Conn HO; Bermann MM; Patrick MJ; Morse SS; Alberts JL
    Hepatology; 1986; 6(1):101-6. PubMed ID: 3943775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.